Psychiatry and Neurology, Neurology · Roanoke, VA
NPI
1447419221
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
3 Riverside Cir
Roanoke, VA, 24016
Phone (540) 224-5170
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,919
122 services
Medicare patients, 2024
57
Average age 65
Drug cost, 2024
$2.2M
758 prescriptions
Company payments, 2025
$25.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lydia J Sharp was code 99214 (office e&m - established), 34 times for 23 patients. In total Lydia J Sharp billed 122 services in 19 codes, and Medicare paid $9,919.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 34 | 23 | $90.72 | $3,084 |
| 99215 Office E&M - Established | Office | 19 | 15 | $120.37 | $2,287 |
By year: 2022 $7,472 for 99 services; 2023 $8,481 for 98 services; 2024 $9,919 for 122 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lydia J Sharp prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 75 prescriptions and refills. In total Lydia J Sharp wrote 758 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 75 | 75 | Under 11 | $1.1M |
| Prednisone Generic | 49 | 71 | Under 11 | $293 |
| Pyridostigmine Bromide Generic | 49 | 81 | Under 11 | $3,626 |
| Riluzole Generic | 48 | 74 | 13 | $13K |
| Baclofen Generic | 48 | 65 | 15 | $799 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 37 | 37 | Under 11 | $272K |
| Pregabalin Generic | 36 | 48 | Under 11 | $2,188 |
| Escitalopram Oxalate Generic | 32 | 34 | Under 11 | $432 |
| Gabapentin Generic | 32 | 51 | Under 11 | $994 |
| Tizanidine Hcl Generic | 28 | 43 | Under 11 | $373 |
| Emflaza Deflazacort | 20 | 20 | Under 11 | $515K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 | 15 | Under 11 | $21.73 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 15 | 15 | Under 11 | $23K |
| Mirtazapine Generic | 14 | 16 | Under 11 | $182 |
| Sodium Chloride 0.9 % Sodium Chloride | 12 | 12 | Under 11 | $52.07 |
Brand drugs: 202 claims; generic drugs: 556 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lydia J Sharp $25.75 ($25.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Argenx US, Inc. with $25.75.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 1 | $25.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.